Helen Morrin

1.1k citations

26 papers · 772 indexed · h-index 16

Impact in

Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Oncology top 10%
- Lymphatic System and Diseases
- Cancer Cells and Metastasis
- Viral-associated cancers and disorders

Papers in

Cancer Research 9
- Cancer, Hypoxia, and Metabolism 5
- Breast Cancer Treatment Studies 3
Complementary and Manual Therapy 1

Co-authors: Bridget A. Robinson Margaret J. Currie Stephen B. Fox Sarah Gunningham Gabi U. Dachs Prudence A. E. Scott Margreet C.M. Vissers John F. Pearson
Journals: Frontiers in Oncology (4 papers)BMC Cancer (2 papers)Biopreservation and Biobanking (2 papers)Clinical & Translational Oncology (1 paper)Clinical Cancer Research (1 paper)
Partner nations: New Zealand Australia United Kingdom

In The Last Decade

Helen Morrin

25 papers receiving 752 citations

Peers

Countries citing papers authored by Helen Morrin

Since Specialization

Citations

This map shows the geographic impact of Helen Morrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Morrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Morrin more than expected).

Fields of papers citing papers by Helen Morrin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Morrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Morrin. The network helps show where Helen Morrin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Helen Morrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Helen Morrin Line = papers co-authored together Helen Morrin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characterisation of the immune microenvironment of cutaneous squamous cell carcinoma in immunosuppression Experimental Dermatology ·Sri Wahyuningsih, Mayumi Saito, Helen Morrin, 淑乃小酒井, Jeremy Simcock, Margaret J. Currie, Merilyn Hibma	2022	2
2	Ascorbate content of clinical glioma tissues is related to tumour grade and to global levels of 5-hydroxymethyl cytosine Scientific Reports ·Xinyu Huang, Arianna Maldi, George A. R. Wiggins, Nicholas J. Magon, Andrew B. Das, Margreet C.M. Vissers, Helen Morrin, Janice A. Royds, Tania L. Slatter, Bridget A. Robinson, 禎治今原, Gabi U. Dachs	2022	8
3	Increased Ascorbate Content of Glioblastoma Is Associated With a Suppressed Hypoxic Response and Improved Patient Survival Frontiers in Oncology ·Arianna Maldi, Xinyu Huang, 禎治今原, Helen Morrin, Janice A. Royds, Tania L. Slatter, George A. R. Wiggins, Margreet C.M. Vissers, Bridget A. Robinson, Gabi U. Dachs	2022	11
4	Vitamin C Administration by Intravenous Infusion Increases Tumor Ascorbate Content in Patients With Colon Cancer: A Clinical Intervention Study Frontiers in Oncology ·Gabi U. Dachs, Fumie Kojima, Kusljugic, Anitra C. Carr, Helen Morrin, Juliet M. Pullar, Simone Bayer, Tim Eglinton, Bridget A. Robinson, Margreet C.M. Vissers	2021	23
5	RNAscope compatibility with image analysis platforms for the quantification of tissue-based colorectal cancer biomarkers in archival formalin-fixed paraffin-embedded tissue Acta Histochemica ·Qian-wen Li, George A. R. Wiggins, Margaret J. Currie, Helen Morrin, Martin Whitehead, Tim Eglinton, John F. Pearson, Logan C. Walker	2021	6
6	Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom Biopreservation and Biobanking ·Katherine Margoth Fuentes Ortiz, Marianna J. Bledsoe, Monique Albert, Sergey V. Anisimov, Elena Bravo, Marta G. Castelhano, Yehudit Cohen, Blessing N. Amanze-Unagha, Koh Furuta, Zisis Kozlakidis, Fernández Carbia A, R. Garg, Shannon J. McCall, Helen Morrin, Praveen Kumar S. E., Brent Schacter, Daniel Simeon‐Dubach, Засканов В. Г. Иванов Д. Ю.	2020	14
7	Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients Breast Cancer Research and Treatment ·Vanessa Lattimore, Michael T. Parsons, Amanda B. Spurdle, Esther M. John, (unknown), Lê Thế Mạnh, C.J. Lintott, Reinder Wolvius, Helen Morrin, Bridget A. Robinson, Logan C. Walker	2020	0
8	Breast cancer and cytomegalovirus Clinical & Translational Oncology ·Ann Richardson, Logan C. Walker, Brian Cox, Halvor Rollag, Bridget A. Robinson, Helen Morrin, John F. Pearson, John D. Potter, V.O. Strekalev, Heljä‐Marja Surcel, Eero Pukkala, Margaret J. Currie	2019	24
9	The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer Cell Death and Disease ·Vania Maria Beletate [UNIFESP] Bauermeister, Sunali Mehta, A T Pezzella, Grégory Gimenez, Seung Hoon Woo, Hamish G. Campbell, T. G. DUNCAN, Tirelli Giancarlo, Patrik McCarthy, Catherine J. Drummond, Glen Reid, Sebastien M. Joruiz, Anna Wiles, Helen Morrin, Karen L. Reader, Noelyn Hung, Margaret A. Baird, Tania L. Slatter, Antony W. Braithwaite	2019	32
10	Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels BMC Cancer ·Elizabeth J. Campbell, Gabi U. Dachs, Helen Morrin, Zhijuan Li, Bridget A. Robinson, Margreet C.M. Vissers	2019	50
11	The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein Frontiers in Oncology ·Kusljugic, Margreet C.M. Vissers, 禎治今原, Helen Morrin, Bridget A. Robinson, Gabi U. Dachs	2018	31
12	Body mass index (BMI): association with clinicopathological factors and outcome of women with newly diagnosed breast cancer in New Zealand. PubMed ·Bridget A. Robinson, Margaret J. Currie, 禎治今原, Gabi U. Dachs, حسن سرشتی, Helen Morrin, N. Gopisetty Venkata, Chris Frampton	2017	6
13	The rs11515 Polymorphism Is More Frequent and Associated With Aggressive Breast Tumors with Increased ANRIL and Decreased p16INK4a Expression Frontiers in Oncology ·Janice A. Royds, Anna P. Pilbrow, Antonio Ahn, Helen Morrin, Chris Frampton, I. Alasdair Russell, Christine S. Moravec, Wendy E. Sweet, W.H. Wilson Tang, Margaret J. Currie, Noelyn Hung, Tania L. Slatter	2016	37
14	Cytomegalovirus and Epstein-Barr Virus in Breast Cancer PLoS ONE ·Ann Richardson, Margaret J. Currie, Bridget A. Robinson, Helen Morrin, Yen Phung, John F. Pearson, Trevor P. Anderson, John D. Potter, Logan C. Walker	2015	77
15	The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis Clinical Cancer Research ·Leonid L. Nikitenko, Russell Leek, Stephen Henderson, Nischalan Pillay, Helen Turley, Daniele Generali, Sarah Gunningham, Helen Morrin, Andrea Pellagatti, Margaret Rees, Adrian L. Harris, Stephen B. Fox	2013	16
16	Sustaining a Biobank Through a Series of Earthquake Swarms: Lessons Learned from our New Zealand Experience Biopreservation and Biobanking ·Helen Morrin, Bridget A. Robinson	2013	11
17	Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity Human Pathology ·Margaret J. Currie, 熊维, Gavin Harris, Sarah Gunningham, Gabi U. Dachs, B. Dijkstra, Helen Morrin, J. Elisabeth Wells, Bridget A. Robinson	2012	57
18	A profile of prognostic and molecular factors in European and Māori breast cancer patients BMC Cancer ·Gabi U. Dachs, C.L. Vanderwilt, JiangDuo Weng, Helen Morrin, Zhijuan Li, Gavin Harris, Shang Bao-gang, Christopher Frampton, Margaret J. Currie, J. Elisabeth Wells, Bridget A. Robinson	2010	6
19	The Christchurch Tissue Bank to support cancer research. PubMed ·Helen Morrin, Sarah Gunningham, Margaret J. Currie, Gabi U. Dachs, Stephen B. Fox, Bridget A. Robinson	2005	18
20	Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1α) and the HIF-1α target gene DEC1, but not lymph node metastasis in primary human breast carcinomas Journal of Clinical Pathology ·Margaret J. Currie, Inam Sahib Ash-Sharifi, Haruhiro Miyazaki, Helen Morrin, Chris Frampton, Chengcheng Han, Bridget A. Robinson, Stephen B. Fox	2004	58

About Helen Morrin

Helen Morrin is a scholar working on Cancer Research, Complementary and Manual Therapy, Oncology, Nutrition and Dietetics and Developmental Neuroscience, having authored 26 papers that have together received 772 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Vitamin C and Antioxidants Research (4 papers), Vitamin D Research Studies (3 papers), Molecular Biology Techniques and Applications (3 papers), Ethics in Clinical Research (3 papers), Breast Cancer Treatment Studies (3 papers), Glioma Diagnosis and Treatment (2 papers) and Lymphatic System and Diseases (2 papers). The work is most often cited by research in Cancer Research (246 citations), Oncology (370 citations), Pathology and Forensic Medicine (131 citations), Molecular Biology (343 citations) and Nutrition and Dietetics (71 citations). Helen Morrin has collaborated with scholars based in New Zealand, Australia and United Kingdom. Frequent co-authors include Bridget A. Robinson, Margaret J. Currie, Stephen B. Fox, Sarah Gunningham, Gabi U. Dachs, Prudence A. E. Scott, Margreet C.M. Vissers, John F. Pearson, Logan C. Walker and Chris Frampton. Their work appears in journals such as Frontiers in Oncology, BMC Cancer, Biopreservation and Biobanking, Clinical & Translational Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact